أرشيف الوسم : TIF News

Gene Therapy & Thalassaemia Version 2.3: A TIF Survey

Millions of people worldwide suffer from inherited non-malignant blood disorders like thalassaemia and sickle cell disease. The culprit: genetic defects in their blood stem cells. One of the novel therapies  for thalassaemia that has stood out recently has undoubtedly been the first and only, one-time, groundbreaking gene therapy for transfusion ...

أكمل القراءة »

The 1st TIF Webinar for Medical Specialists scheduled for 11 May

The 1st webinar for Medical Specialists organised in the context of TIF’s eThalEd online course has just arrived! Dr Antonio Piga, Professor of Paediatrics & Dean of the Medicine School at San Luigi University Hospital of the Turin University, will be the host of this introductory webinar entitled ”Access to New Therapies: Reblozyl”. ...

أكمل القراءة »

JUST LANDED: A new TIF Publication on Blood & COVID-19

Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and others provide with regard to adequacy and safety of blood and its products? This brand new informational guide about ...

أكمل القراءة »